What is diabetic ketoacidosis in a patient with a fasting blood glucose of 600 mg/dL?

Understanding Diabetic Ketoacidosis (DKA) in Your Patient with Blood Glucose of 600 mg/dL

Your patient with a fasting blood glucose of 600 mg/dL may have either diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), and you must immediately check venous pH, bicarbonate, and ketones to distinguish between these two life-threatening conditions 1.

What is Diabetic Ketoacidosis?

DKA is a life-threatening hyperglycemic emergency defined by three specific criteria 2, 3:

• Blood glucose >250 mg/dL (though it can be much higher, as in your patient)
• Venous pH <7.3
• Serum bicarbonate <15 mEq/L
• Presence of ketones in blood or urine
• Elevated anion gap metabolic acidosis

Critical Distinction: DKA vs. HHS

With a glucose of 600 mg/dL, you're at the threshold where HHS becomes more likely than DKA 1. Here's how to differentiate:

DKA characteristics:

• Glucose typically 250-600 mg/dL
• pH <7.3
• Significant ketosis present
• More common in younger patients with type 1 diabetes
• Mortality: 1-5% 2

HHS characteristics:

• Glucose >600 mg/dL
• pH >7.3
• Bicarbonate >15 mEq/L
• Minimal or no ketones
• Altered mental status or severe dehydration prominent
• More common in older patients with type 2 diabetes
• Mortality: up to 20% 4

Immediate Diagnostic Workup

Obtain these labs STAT 1:

• Venous blood gas (pH is key—arterial not necessary)
• Serum electrolytes with anion gap calculation
• Blood glucose
• Blood urea nitrogen and creatinine
• Serum ketones (β-hydroxybutyrate preferred over nitroprusside method)
• Urinalysis for ketones
• Complete blood count
• Calcium and phosphorus
• Osmolality

Important Pitfall: Ketone Measurement

Do not rely on urine ketone strips or nitroprusside methods to monitor treatment response 1. These only measure acetoacetate and acetone, not β-hydroxybutyrate (the predominant ketone in DKA). During treatment, β-hydroxybutyrate converts to acetoacetate, which can falsely suggest worsening ketosis when the patient is actually improving.

Pathophysiology Explained

DKA occurs due to absolute or relative insulin deficiency combined with elevated counter-regulatory hormones (glucagon, cortisol, catecholamines) 2, 3:

1. Insulin deficiency prevents glucose uptake by cells, causing hyperglycemia
2. Lipolysis accelerates, releasing free fatty acids
3. Liver converts fatty acids to ketone bodies (β-hydroxybutyrate, acetoacetate, acetone)
4. Ketones accumulate, causing metabolic acidosis
5. Osmotic diuresis from hyperglycemia causes severe dehydration and electrolyte losses

Clinical Presentation to Expect

Your patient may present with 2:

• Polyuria and polydipsia (98% of cases)
• Weight loss (81%)
• Fatigue (62%)
• Dyspnea/Kussmaul respirations (57%)—deep, labored breathing compensating for acidosis
• Vomiting (46%)
• Abdominal pain (32%)
• Altered mental status (especially if HHS)
• Fruity breath odor (from acetone)
• Dehydration signs: tachycardia, hypotension, poor skin turgor

Treatment Algorithm

1. Fluid Resuscitation (First Priority)

Start immediately with isotonic saline 1:

• Initial bolus based on hydration status
• Maintenance at 1.5 times 24-hour requirements (approximately 5 mL/kg/h)
• Do not exceed 2 times maintenance to avoid cerebral edema risk
• Switch to hypotonic saline based on corrected sodium and hemodynamic status

2. Insulin Therapy

For moderate to severe DKA, use continuous IV insulin infusion (Grade B recommendation) 1:

• Do NOT give insulin bolus initially—start with continuous infusion
• Target glucose decline: 50-75 mg/dL per hour
• If glucose not declining adequately, check hydration first, then consider doubling insulin rate hourly 1

For mild DKA only:

• Priming dose: 0.4-0.6 units/kg (half IV bolus, half SC/IM)
• Then 0.1 units/kg/hour SC or IM 1

3. Potassium Replacement (Critical)

Add potassium to IV fluids 1:

• Use 1/3 potassium phosphate and 2/3 potassium chloride or acetate
• Monitor potassium every 2-4 hours
• Avoid cardiac arrhythmias from hypokalemia (insulin drives potassium intracellularly)

4. Bicarbonate Therapy

Only consider if pH <6.9 (Grade C recommendation) 1:

• No benefit shown for pH ≥7.0
• May be beneficial in severe acidosis to prevent cardiac dysfunction

5. Phosphate Replacement

Generally not necessary (Grade A evidence shows no clinical benefit) 1:

• Consider only if:
  • Cardiac dysfunction present
  • Anemia present
  • Respiratory depression present
  • Serum phosphate <1.0 mg/dL

Monitoring During Treatment

Draw labs every 2-4 hours 1:

• Serum electrolytes
• Glucose
• BUN and creatinine
• Venous pH (not arterial—venous is adequate)
• Anion gap
• Osmolality

Resolution Criteria

DKA is resolved when ALL of the following are met 1:

• Glucose <200 mg/dL
• Serum bicarbonate ≥18 mEq/L
• Venous pH ≥7.3

Transition to Subcutaneous Insulin

Critical timing to prevent rebound hyperglycemia 1:

• Start subcutaneous insulin regimen (combination of short/rapid-acting and intermediate/long-acting)
• Continue IV insulin for 1-2 hours AFTER starting subcutaneous insulin
• Abrupt discontinuation of IV insulin causes poor glycemic control

If patient is NPO after resolution:

• Continue IV insulin
• Supplement with subcutaneous regular insulin every 4 hours
• Give 5-unit increments for every 50 mg/dL above 150 mg/dL (up to 20 units for glucose 300 mg/dL)

Special Considerations for Your Patient

Age and Diabetes Type

• One-third of DKA cases occur in patients without known diabetes 2
• 14% of cases occur in patients >70 years
• 23% in ages 51-70
• Your patient's age will help determine if this is new-onset type 1 vs. type 2 diabetes

Precipitating Factors to Investigate

Look for:

• Infection (40% have preceding febrile illness) 2
• Medication non-compliance
• New-onset diabetes
• Myocardial infarction
• Stroke
• Pancreatitis
• Medications (atypical antipsychotics like risperidone can precipitate DKA) 5

Cerebral Edema Risk (Especially in Children)

This is the most feared complication 1:

• More common in pediatric patients
• Caused by overly rapid correction of glucose and osmolality
• Prevent by gradual correction and judicious fluid choice
• Use isotonic or hypotonic saline based on corrected sodium

Key Pitfalls to Avoid

1. Starting insulin before adequate fluid resuscitation—can worsen hypotension
2. Stopping IV insulin abruptly—causes rebound hyperglycemia and ketosis
3. Using nitroprusside ketone tests to monitor response—gives false impression of worsening
4. Ignoring potassium replacement—leads to life-threatening arrhythmias
5. Correcting glucose too rapidly—increases cerebral edema risk
6. Assuming it's DKA without checking pH and ketones—could be HHS with different mortality risk

Bottom Line for Your Patient

With a glucose of 600 mg/dL, immediately obtain venous pH, bicarbonate, and ketones to determine if this is DKA (pH <7.3, ketones present) or HHS (pH >7.3, minimal ketones) 1. Start IV fluids immediately while awaiting labs. If DKA is confirmed, begin continuous IV insulin infusion and monitor closely every 2-4 hours until resolution criteria are met. The distinction matters because HHS carries significantly higher mortality (up to 20% vs. 1-5%) and requires slightly different management approaches 4.